Dr. Thakrar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4736 Osage Ave
Philadelphia, PA 19143Phone+1 610-653-2406
Education & Training
- Johns Hopkins UniversityResidency, Internal Medicine, 2017 - 2020
- Perelman School of Medicine at the University of PennsylvaniaClass of 2017
Certifications & Licensure
- PA State Medical License 2021 - 2024
- MD State Medical License 2018 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Preventive Medicine Addiction Medicine
Publications & Presentations
PubMed
- Wound Characteristics Among Patients Exposed to Xylazine.Lydia Lutz, Rachel McFadden, Lin Xu, Ranvir Bhatia, M Holliday Davis
JAMA Dermatology. 2024-11-13 - 2 citationsBuprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl.Ashish P Thakrar, Paul J Christine, Andrew Siaw-Asamoah, Anthony Spadaro, Sophia Faude
JAMA Network Open. 2024-09-03 - Revisiting dezocine for opioid use disorder: A narrative review of its potential abuse liability.Gordon A Barr, Heath D Schmidt, Ashish P Thakrar, Henry R Kranzler, Renyu Liu
CNS Neuroscience & Therapeutics. 2024-09-01
Press Mentions
- One in Six Patients with Opioid Use Disorder Leaving the Hospital Before Completing Treatment, Potentially Due to Untreated Withdrawal SymptomsDecember 4th, 2023
- Inside the Emerging Xylazine Addiction Crisis in the U.S.May 18th, 2023
- Opinion: Overdose Crisis Demands Wider Access Not Just to Narcan, but Also to MethadoneApril 10th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: